ID
22550
Beschrijving
ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00350051
Link
https://clinicaltrials.gov/show/NCT00350051
Trefwoorden
Versies (1)
- 07-06-17 07-06-17 -
Geüploaded op
7 juni 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Prostate Cancer NCT00350051
Eligibility Prostate Cancer NCT00350051
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Cytotoxic Chemotherapy Prostate carcinoma
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0677881
- UMLS CUI [1,2]
- C0600139
Beschrijving
Investigational New Drugs
Datatype
boolean
Alias
- UMLS CUI [1]
- C0013230
Beschrijving
Brain Neoplasms Symptomatic | Radiotherapy to brain Patient need for
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0006118
- UMLS CUI [1,2]
- C0231220
- UMLS CUI [2,1]
- C0948319
- UMLS CUI [2,2]
- C0686904
Beschrijving
Communicable Disease
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009450
Beschrijving
Exclusion Criteria Additional
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0680251
- UMLS CUI [1,2]
- C1524062
Similar models
Eligibility Prostate Cancer NCT00350051
- StudyEvent: Eligibility
C0332120 (UMLS CUI [1,2])
C0242656 (UMLS CUI [2])
C1524062 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,2])
C0948319 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])
C1524062 (UMLS CUI [1,2])